Management Forum Logo

Presented by
Management Forum

Pharmaceutical Regulatory Affairs in Africa Training Course

Covering the key regions of South Africa, Namibia, Zimbabwe, Zambia, Malawi, Tanzania, Kenya, Uganda, Nigeria, Ghana and Maghreb countries - Algeria, Morocco, Tunisia

★★★★★ "Presentations/content and speakers were well rounded and provided valuable information for my job th... more (10)"

17-18 June 2024
+ 19-22 November 2024 »

from £1099

Need help?  Enrol or reserve

Course Overview

The value of the African pharmaceutical market is increasing and growth is expected to continue at a rapid pace. There are a number of distinct markets within the region, each with their own economic and regulatory characteristics. This event will explore the key areas of African regulatory affairs, including the new SAHPRA guidelines in South Africa, and will focus on practical aspects to assist with your regulatory activities. The expert speakers will share their knowledge of working in the region and the programme will include interactive discussion sessions to enable you to share experiences with other delegates.

Covering the key regions of Algeria, Botswana, Ethiopia, Ghana, Kenya, Malawi, Morocco, Mozambique, Namibia, Nigeria, South Africa, Tanzania, Tunisia, Uganda, Zambia, Zimbabwe.

Benefits of attending:

  • Gain an overview of the regulatory requirements within African countries
  • Understand requirements for company and product registration
  • Learn practical information on compiling dossiers
  • Discuss the new SAHPRA guidelines in South Africa
  • Explore the harmonisation and cooperation initiatives in Africa, including the new African Medicines Agency

Participants will receive a course material folder containing comprehensive documentation provided by the speakers, which will be a valuable source of reference for the future.

This course is part of our Regulatory Affairs Training course collection, which features updates on the latest regulations to registration procedures and strategies.

Who should attend?

This event will be of particular interest to all those who need to learn about successful marketing authorisation applications and regulatory compliance in key African areas. It will be useful as both an introductory and a refresher course on recent developments.

Enrol or reserve

The Pharmaceutical Regulatory Affairs in Africa course will cover:

Basic terms & environment

Harmonisation initiatives within Africa

Regional presentations

Each regional presentation will cover:

  • The development of drug control
    • The regulatory authorities
    • Other influences
  • Regulatory submission strategy
    • How to determine an appropriate submission strategy
    • A practical approach
  • The development of drug control
    • The regulatory authorities
    • Other influences
  • Company and product registration
    • Regulations and guidelines
    • New products and line extensions
    • Labelling requirements
    • Registration samples and certification/legalisation
  • Compilation of the dossiers
    • Contents and formats
    • Hints on success/failure
    • Specific country requirements
  • Regulatory authority/agency assessment
    • Process
    • Timelines

South Africa

  • Influences and changes
  • The new SAHPRA guidelines
  • Latest regulatory processes adopted by SAHPRA
  • Complementary and alternative medicines status
  • Marketing code for the advertising of medicines

Namibia

Botswana

Zimbabwe

Zambia

Malawi

Tanzania

Kenya

Uganda

Nigeria

Ghana

Maghreb Countries - Algeria, Morocco, Tunisia

Final discussion session

Enrol or reserve

Salma Ismail
Twinz Regulatory Affairs Pharmacist Consultants

Salma Ismail is the CEO of Twinz Regulatory Affairs Pharmacist Consultants based in South Africa. Salma has over 20 years of experience within the Pharmaceutical Industry and in Regulatory Affairs, which includes understanding of legislation, technical issues, marketing regulations and training people within the pharmaceutical industry.
Her company is very involved with the submission of product applications for registration to regulatory authorities in South Africa and English speaking Africa for products from a diverse area that includes new chemical entities, generic molecules, biological medicines, complementary medicines including health supplements, medical devices and applications to regulatory authorities within the SADC region. Her company also deals with product life cycle maintenance by dealing with variations for submission to the authorities.
She is also involved in academia by lecturing on relevant pharmaceutical regulatory matters in prestigious universities in South Africa as well as training people from within the pharmaceutical industry environment. Salma is the former Chairperson of SAPRAA (Southern African Pharmaceutical Regulatory Affairs Association).

More details

Makram Nehme

Makram Nehme is a Regional Regulatory Consultant having relevant experience with multiple multinationals including Parexel international, based in Lebanon. He has more than 10 years’ experience in the Pharmaceutical and Medical Device Industry and is a Regulatory Expert covering the Middle East and North African markets. His experience includes negotiations with the Ministry of Health and Drug Agencies in the region, as well as training of key personnel and he has a proven record in regulatory submissions, analysis, product pricing and reimbursement across the MENA region.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

17-18 June 2024

Live online

09:30-16:00 UK (London) (UTC+01)
10:30-17:00 Paris (UTC+02)
04:30-11:00 New York (UTC-04)
Course code 13818

  • GBP 1,099 1,299
  • EUR 1,589 1,869
  • USD 1,817 2,129

Until 13 May

View basket 

 
Not ready to book yet?

for 7 days, no obligation

19-22 November 2024

Live online

13:30-17:00 UK (London) (UTC+00)
14:30-18:00 Paris (UTC+01)
08:30-12:00 New York (UTC-05)
Course code 14028

  • GBP 1,099 1,299
  • EUR 1,589 1,869
  • USD 1,817 2,129

Until 15 Oct

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

Reviews of IPI's Pharmaceutical Regulatory Affairs in Africa training course


Presentations/content and speakers were well rounded and provided valuable information for my job that showed the experience they had to give me confidence in the information provided. The whole program, process and all was well worth the cost and time. I will recommend to others - already have!

May 26 2021

Angela Turner
RA Director,

Nov 11 2020

Very good, especially the opportunity to ask specific questions to the speaker with so much experience on the field.

Laia Gispert
Regulatory affairs Expert, GALENICUM HEALTH, S.L.

Oct 1 2018

Salma Ismail was very good. She did speak with passion and I liked her way how she presented the different topics. Makram Nehme was also very good.

Hildur Sif Pálmarsdóttir
Submission Manager, LEO Pharma

Oct 1 2018

Fantastic speaker, really experienced and able to give real 'examples' of dealing with the authorities. Lovely to be able to ask questions so readily (rather than at the end of the topic/country) - this made the day much more interesting/interactive, which I much prefer.

Joanne Breare
Regulatory Affairs Coor, Colorcon Ltd

Oct 2 2017

I thoroughly enjoyed the course and would strongly recommend to anyone who is operating in this region, irrespective of whether they are a seasoned pro in this region or new to it.

Mark Pellett
Associate Director, Biogen Idec Ltd

Oct 2 2017

Very satisfied, clear detail that are very helpful

Thomas Carter
Regulatory Project Manager, Abbott Laboratories Limited

Oct 2 2017

Very useful in my day-to-day job, thanks to Selma and Makram for their time and sharing their expertise.

Julia Bradley
Associate Manager, Gilead Sciences International

Oct 4 2016

I learnt a lot from this course, I am glad that it was taught based on experience rather than just being taught the guidelines. The information about how the process actually works rather than how it should work was very helpful.

Olivia Blanchet
Regulatory Affairs Associate, Besins Healthcare

Oct 4 2016

It was an amazing course, the speakers were experienced and the content of the course fitted with my expectations. It was also great to share and compare experiences in the area.

Nicoleta Vizi
Jr. Manager Global Regulatory Affairs, B. Braun Pharmaceuticals

Oct 4 2016

Good speakers

Marta Abascal
International Market Access, Laboratorios Cinfa, S.A.

United Kingdom

  • Abbott Laboratories Limited
  • Abbott Laboratories Ltd
  • Abbvie Ltd
  • Allergan UK Limited
  • Almac Group
  • Amdipharm Mercury Company Limited
  • Amgen Ltd
  • AstraZeneca UK Ltd
  • Besins Healthcare
  • Biogen Idec Ltd
  • Boehringer Ingelheim Ltd
  • Britannia Pharmaceuticals Ltd
  • Business Monitor International Ltd
  • Cambridge Healthcare Supplies Ltd
  • Celgene Europe Ltd
  • Chugai Pharma Europe Ltd
  • Colorcon Ltd
  • Eisai Ltd
  • Gilead Sciences
  • Gilead Sciences International
  • Gilead Sciences International Limited
  • GlaxoSmithKline
  • Informa Healthcare Limited
  • Janssen Research and Development
  • Janssen-Cilag Ltd
  • Martindale Pharma
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Oluwakemi Bankole
  • Reckitt Benckiser Healthcare (UK) Ltd
  • Shire Pharmaceutical Ltd
  • Stiefel Labs (UK) Limited
  • Subiaco Associates Ltd
  • Teva UK Ltd
  • Waymade Plc
  • Xidea Solutions

France

  • Abbott
  • Fresenius Kabi
  • Groupe Servier
  • Guerbet
  • Horus Pharma
  • Ipsen Pharma SAS
  • LES LABORATOIRES SERVIER
  • Merck Sante s.a.s.
  • Pierre Fabre Medicament
  • Sanofi Pasteur SA
  • Sanofi Synthelabo Recherche
  • Sanofi-Aventis Recherche & Development
  • SEPTODONT

Germany

  • ABBOTT GmbH & Co KG
  • Abbott Laboratories GmbH
  • Bayer Pharma AG
  • Boehringer Ingelheim Vetmedica GmbH
  • CHEPLAPHARM Arzneimittel GmbH
  • Cheplapharm Arzneimittel GmbH
  • Engelhard Arzneimittel GmbH KG
  • Grunenthal GmbH
  • Helm AG
  • Hexal AG
  • Intendis GmbH
  • Merck KGaA
  • Parexel International GmbH

Switzerland

  • AbbVie
  • Acino Pharma AG
  • CSL Behring AG
  • F. Hoffmann-La Roche Ltd
  • Medicines for Malaria Venture
  • Merck Serono SA
  • Novartis Consumer Health SA
  • Swiss Tropical Institute
  • Vifor SA

Denmark

  • Ferring Pharmaceuticals A/S
  • LEO Pharma
  • Leo Pharma A/S
  • Novo Nordisk A/S
  • Pharmanovia A/S
  • Statens Serum Institut

Belgium

  • Dafra Pharma International
  • Galapagos NV
  • Janssen Infectious Diseases - Diagnostics BVBA
  • Janssen Pharmaceutica NV
  • UCB Pharma SA

South Africa

  • Cliffe Dekker Hofmeyr Inc
  • Hogan Lovells
  • NOVO NORDISK
  • Sanofi-Aventis South Africa
  • Schering-Plough (Pty) Ltd

Spain

  • Faes Farma
  • FAES FARMA, S.A.
  • FAES Pharma SA
  • GALENICUM HEALTH, S.L.
  • Laboratorios Cinfa, S.A.

United States of America

  • Abbott Laboratories
  • BioMarin Pharmaceutical Inc
  • International Partnership for Microbicides
  • Mr W Pagsuyuin
  • United States Department of Commerce

Greece

  • Demo SA Pharmaceutical Industry
  • LEO Pharma A/S
  • Leo Pharmaceutical Products Sarath Ltd
  • NOVO NORDISK AS

United Arab Emirates

  • Astrazeneca Gulf
  • Hospira (ME & NA)
  • LEO Pharma

Israel

  • Teva
  • Teva Pharmaceutical Industries Ltd

Italy

  • Menarini Ricerche
  • Menarini Ricerche S.p.A.

Netherlands

  • Astellas Pharma International BV
  • Merck Sharp & Dohme

Poland

  • Adamed Sp. z o.o.
  • Valeant Sp. z o.o. sp.j

Austria

  • Baxter Innovations GmbH

Cyprus

  • Delorbis Pharmaceuticals Ltd

Czech Republic

  • Zentiva ks

Iceland

  • Actavis Group PTC

India

  • Ranbaxy Laboratories Limited

Ireland

  • Labopharm Europe Ltd

Kenya

  • KEMRI Wellcome Trust Research Programme

Norway

  • GE Healthcare AS

Pakistan

  • Remington Pharmaceuticals

Portugal

  • TECNIMEDE SA

Romania

  • B. Braun Pharmaceuticals

Thailand

  • Concept Foundation

Enrol or reserve

Run Pharmaceutical Regulatory Affairs in Africa Live online for your team

2 days

Typical duration

Pricing from:

  • GBP 800
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra BEER
Training expert

Yesim Nurko

Yesim NURKO
Training expert

+44 (0)20 7749 4749

inhouse@ipi.academy